Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy ...

For the first time, FDA regulators will be able to see what’s happening in a clinical trial, looking at endpoints in the ...

High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...

An FDA initiative to implement real-time clinical trials could dramatically accelerate the pace at which new treatments ...

The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT). First, the agency unveiled the ...

Laboratory experiments exposed E. coli and MRSA to Nu-3 for 21 days. The minimum inhibitory concentration (MIC) changed in E. coli, while MRSA showed no change.

Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward” or the "Company”), a global leader in innovative medical technology to transform the ...

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

Hospitals filled to capacity. Case counts climbing by the hour. Quarantine became routine. It was the beginning of the ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, announced today that it has entered ...